
Experienced public & private co. CEO & business consultant
Greater San Diego Area

Experienced public & private co. CEO & business consultant
Greater San Diego Area
A tough-minded executive known for visionary leadership in high growth and underperforming businesses. Larry G Stambaugh is a principal at Apercu Consulting, where he serves as an advisor to private and public boards and management, including clean tech and life sciences companies. He is the former Chief Executive Officer and President of Calando Pharmaceuticals, Inc, and Chairman, CEO and President of Maxim Pharmceuticals,. Mr. Stambaugh also was the Chairman & CEO of ABC Laboratories, a world leading environmental services and manufactring company. During his more than 35-year career Mr. Stambaugh has faced and solved many of the toughest business problems that can challenge a company. As a top executive his visionary leader has built management teams and companies around “A humble heart and an open mind”. He has led the turnaround of organizations through setting strategic initiatives with the board and management for new directions and priorities. His well developed process has effectively guided the board and management to realistically access their strengths and weakness and direct the organization into new businesses and discontinue underperforming activities and business units. Mr. Stambaugh has raised nearly $400 million of capital in private and public financing. He has taken a company public in both the U.S. and Europe. In times of weak financing markets he has found creative alternatives for financing including, PIPE transactions, syndicated bank loans, reverse mergers, corporate collaborations and private equity funding.
Mr. Stambaugh has had a focus on board activities and corporate governance practices for nearly three decades. He has more nearly 100 years of board service and speaks on the best practices and current issues in corporate governance. In 2002, 2006 and for an unprecedented third time in 2007 he was awarded the “Director of the Year” recognition for his work in corporate governance leadership and education.
Experienced top executive in a clean tech, life sciences company, contract research services company, equipment manufacturer, retail sales company, mulit- bank commercial banking company and business consulting
(Environmental Services industry)
February 2006 — Present (2 years 6 months)
Principal at Apercu Consulting, where Mr. Stambaugh serves as an advisor to private and public boards and management. During his more than 35-year career Mr. Stambaugh has faced and solved many of the toughest business problems that can challenge a company. He is also active in board governance and serves on several boards, including, Precision Human Biolaboratories,Assure Controls, EcoDog, Inc., Virtual Reality Medical Center, BioCom, and Corporate Directors Forum
(Public Company; MAXM; Biotechnology industry)
December 1992 — January 2006 (13 years 2 months)
Raised over $350 million including private equity, IPO in the U.S and follow-on secondary and PIPE transactions. Listed company on public markets in Europe while growing market capitalization from $15 million to $1.5 billion.
Prepared initial business plan, assembled highly experienced management team and acquired technologies in cancer and liver disease.
Conducted 17 clinical trials in 20 countries on three continents, and presented complex science to and negotiated strategic partnerships with Fortune 100 pharmaceutical companies.
Divested of diagnostic division and acquired exclusive worldwide rights to apoptosis technologies through the acquisition of a biotechnology company.
Identified and completed a strategic transaction to merge Maxim with a New Jersey biotech company after the Company had negative clinical trial results and FDA delays.
(Environmental Services industry)
1989 — 1992 (3 years)
Recruited to restructure an international environmental services and instrument manufacturing company with growing pains and significant customer service issues. The top priorities were to take advantage of a growing market, provide capital for expansion, and assemble a management team and leading scientists to serve Fortune 500 customers.
• Doubled sales from $9.7 million to $21 million, achieved record earnings, and returned over 20% on beginning equity.
• Attracted and hired over 200 new associates, including renowned world leaders in environmental science and many advanced degree scientists.
• Instituted intensive training program to develop management skills, communication abilities, integration of new associates into Company, and focus on quality concepts.
• Directed company’s offshore expansion, resulting in over 25% of sales from Europe and Pacific Rim.
BBA, Accounting / Finance, September 1965 — May 1969
Clean technology, innovation, corporate governance, golf, photography, travel,
Chairman of the Board, Precision Human Biolaboratories, Board of Directors and Audit Committee, Elixir Industries, Board of Directors and Executive Committee BIOCOM, Board of Directors and Executive Committee - Corporate Directors Forum, Business Advisory Board - Rady School of Management, UCSD, lee hecht harrison, ACG
Corporate Director of the Year Award, San Diego Technology Fast 50 Company Award, CONNECT Most Innovative Product Award, Honorary Chairman - American Liver Foundation Annual Dinner, and Community Caring Award - Billy Foundation.
Frequent speaker in over 49 publications and meetings on corporate governance and executive leadership.